These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8392288)

  • 1. Antiemetic efficacy of alprazolam in the combination of metoclopramide plus methylprednisolone. Double-blind randomized crossover study in patients with cisplatin-induced emesis.
    Mori K; Saito Y; Tominaga K
    Am J Clin Oncol; 1993 Aug; 16(4):338-41. PubMed ID: 8392288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Usefulness of alprazolam in controlling cisplatin-induced emesis].
    Mori K; Saitoh Y; Tominaga K; Yokoi K; Miyazawa N
    Gan To Kagaku Ryoho; 1991 Apr; 18(4):631-5. PubMed ID: 1849392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A combined anti-emesis therapy of oral prednisolone and alprazolam for cisplatin-induced delayed emesis].
    Watanabe A; Horio Y; Minami H; Shibagaki T; Iwahara T; Sakai S; Shimokata K
    Gan No Rinsho; 1990 Jul; 36(8):881-4. PubMed ID: 2164113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiemetic activity of high-dose methylprednisolone associated with continuous-infusion metoclopramide and oral alprazolam during multiple-day chemotherapy.
    Salles G; Archimbaud E; Thomas X; Fiere D
    Cancer Chemother Pharmacol; 1991; 28(1):77-9. PubMed ID: 2040038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral granisetron with or without methylprednisolone versus metoclopramide plus methylprednisolone in the management of delayed nausea and vomiting induced by cisplatin-based chemotherapy. A prospective randomized trial.
    Gebbia V; Testa A; Valenza R; Cannata G; Tirrito ML; Gebbia N
    Cancer; 1995 Nov; 76(10):1821-8. PubMed ID: 8625054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral combination antiemetics in patients with small cell lung cancer receiving cisplatin or cyclophosphamide plus doxorubicin.
    Cleri LB; Kris MG; Tyson LB; Pisters KM; Clark RA; Gralla RJ
    Cancer; 1995 Sep; 76(5):774-8. PubMed ID: 8625179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, double-blind comparison of a prochlorperazine-based versus a metoclopramide-based antiemetic regimen in patients undergoing autologous bone marrow transplantation.
    Gilbert CJ; Ohly KV; Rosner G; Peters WP
    Cancer; 1995 Dec; 76(11):2330-7. PubMed ID: 8635039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of continuous and intermittent bolus infusions of metoclopramide during 5-day continuous intravenous infusion with cisplatin.
    Mori K; Saitou Y; Tominaga K; Yokoi ; Miyazawa N
    Eur J Cancer; 1991; 27(6):729-32. PubMed ID: 1648944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ondansetron + dexamethasone vs metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin-induced emesis. Italian Group For Antiemetic Research.
    Lancet; 1992 Jul; 340(8811):96-9. PubMed ID: 1352024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical Research.
    Roila F; Tonato M; Basurto C; Picciafuoco M; Bracarda S; Donati D; Malacarne P; Monici L; Di Costanzo F; Patoia L
    J Clin Oncol; 1989 Nov; 7(11):1693-700. PubMed ID: 2681556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the efficacy of tropisetron versus a metoclopramide cocktail based on the intensity of cisplatin-induced emesis.
    Chang TC; Hsieh F; Lai CH; Tseng CJ; Cheng HH; Li CL; Michael BJ; Soong YK
    Cancer Chemother Pharmacol; 1996; 37(3):279-85. PubMed ID: 8529290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind crossover trial of single vs. divided dose of metoclopramide in a combined regimen for treatment of cisplatin-induced emesis.
    Roila F; Basurto C; Bracarda S; Sassi M; Lupattelli M; Picciafuoco M; Boschetti E; Tonato M; Del Favero A
    Eur J Cancer; 1991; 27(2):119-21. PubMed ID: 1827271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective randomized double-blind crossover study comparing the antiemetic activity of alizapride and metoclopramide in patients receiving cisplatin chemotherapy.
    Basurto C; Roila F; Del Favero A; Ballatori E; Minotti V; Tonato M
    Cancer Invest; 1988; 6(5):475-9. PubMed ID: 3063335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained-release metoclopramide plus methylprednisolone versus placebo plus methylprednisolone as antiemetic prophylaxis during non-cisplatin chemotherapy. A randomized double-blind cross-over trial.
    Hansen O; Pfeiffer P; Madsen B; Andersen I; Hansen B; Mathiesen B
    Acta Oncol; 1996; 35(1):57-61. PubMed ID: 8619941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized comparison of the antiemetic efficacy of a serotonin type 3 receptor antagonist (MDL 72,222) with a high-dose metoclopramide regimen.
    Homesley HD; Hahne WF; McLees B; Heck K; Barrett RJ; Lentz SS; Woodlief L; Lovelace JV
    Am J Clin Oncol; 1993 Apr; 16(2):175-9. PubMed ID: 8452114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin.
    Kris MG; Gralla RJ; Tyson LB; Clark RA; Cirrincione C; Groshen S
    J Clin Oncol; 1989 Jan; 7(1):108-14. PubMed ID: 2642536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised, double-blind comparison of granisetron with high-dose metoclopramide, dexamethasone and diphenhydramine for cisplatin-induced emesis. An NCI Canada Clinical Trials Group Phase III Trial.
    Warr D; Wilan A; Venner P; Pater J; Kaizer L; Laberge F; Latreille J; Stewart D; O'Connell G; Osoba D
    Eur J Cancer; 1992; 29A(1):33-6. PubMed ID: 1332737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The prevention of CDDP-induced emesis with a combination regimen including metoclopramide, dexamethasone, droperidol and diphenhydramine].
    Dozono H; Yasuda M; Yokoyama S; Takahashi S; Ochiai K; Tsuruoka M; Morimoto O; Sasaki H; Arihiro T; Terashima Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Nov; 39(11):1968-72. PubMed ID: 3429979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ondansetron plus dexamethasone compared to the 'standard' metoclopramide combination.
    Roila F
    Oncology; 1993; 50(3):163-7. PubMed ID: 8459986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.